Atopic Dermatitis Clinical Trials

A listing of 55 Atopic Dermatitis clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Atopic Dermatitis

1 - 12 of 55

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 55 active clinical trials seeking participants for Atopic Dermatitis research studies. The states with the highest number of trials for Atopic Dermatitis participants are California, Florida, Texas and Ontario.

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Atopic Dermatitis Clinical Study

Recruiting

We are looking for people who are diagnosed with atopic dermatitis to join our latest clinical research study. Help us as we aim to find out more about an investigational medication for atopic dermatitis.

 Payment up to $1300, which varies by study
 Compensation for time and study-related travel
 Study medication at no cost
 Study-related care from specialist doctors

Conditions:

Atopic Dermatitis

Atopic

Dermatitis

Atopic

Atopic Dermatitis Eczema

Learn More

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

NCT06832618

Recruiting

The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to \<18 Years Old) with moderate atopic dermatitis.

Gender:

ALL

Ages:

Between 6 years and 17 years

Trial Updated:

06/30/2025

Locations: Clinical Research Center of Alabama, Birmingham, Alabama +91 locations

Clinical Research Center of Alabama, Birmingham, Alabama

Saguaro Dermatology, Phoenix, Arizona

National Jewish Health, Denver, Colorado

Cleaver Medical Group, Cumming, Georgia

Treasure Valley Medical Research, Boise, Idaho

Sneeze Wheeze and Itch Associates Llc, Normal, Illinois

Raven Clinical Research, Marriottsville, Maryland

Henry Ford Health System, Detroit, Michigan

University of Mississippi Medical Center, Jackson, Mississippi

Medisearch Clinical Trials, Saint Joseph, Missouri

University of Rochester Medical Center, Rochester, New York

Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio

University of Texas Physicians - Bellaire Station, Bellaire, Texas

Medical College of Wisconsin, Milwaukee, Wisconsin

Cliniques Universitaires Ucl Saint-Luc, Brussels, Not set

Az Sint-Lucas, Gent, Not set

Universitair Ziekenhuis Gent, Gent, Not set

Les Viviers, Gilly, Not set

Centre Hospitalier Universitaire de Liege - Sart Tilman, Liege, Not set

Dermatologie Maldegem, Maldegem, Not set

Medical Centre 'Asklepii', Ood, Dupnitsa, Not set

Mhat Dr. Tota Venkova Ad, Gabrovo, Not set

Dcc 'Alexandrovska', Eood, Sofia, Not set

Diagnostic Consultative Center Xxviii, Sofia, Not set

Medical Center Assoc. Prof. Vasilev, Sofia, Not set

Dermatology Research Institute Inc., Calgary, Alberta

Laster Rejuvenation Clinics Edmonton D.T. Inc., Edmonton, Alberta

University of British Columbia (Ubc) - British Columbia Children'S Hospital (Bc Children'S Hospital), Vancouver, British Columbia

Winnipeg Clinic, Winnipeg, Manitoba

Leader Research, Hamilton, Ontario

Facet Dermatology, Toronto, Ontario

Chu Sainte-Justine, Montréal, Quebec

Skinsense Medical Research, Saskatoon, Saskatchewan

K. Papp Clinical Research, Ontario, Not set

Chu de Québec-Université Laval, Quebec, Not set

Skincare Studio Dermatology Centre, St. John's, Not set

Bordeaux Chu Hopital Saint - Andre, Bordeaux, Not set

Polyclinique Reims-Bezannes, Reims, Not set

Hopitaux Drome Nord, Romans-sur-isère, Not set

Fachklinik Bad Bentheim Dermatologie, Bad Bentheim, Not set

St. Josef-Hospital Universitaetsklinikum, Bochum, Not set

Universitatsklinikum Bonn Aoer, Bonn, Not set

Drk Krankenhaus Chemnitz-Rabenstein, Chemnitz, Not set

Universitaetsklinikum Carl Gustav Carus Tu Dresden, Dresden, Not set

Universitatsklinikum Frankfurt, Frankfurt, Not set

Universitatsmedizin Goettingen, Goettingen, Not set

Universitaetsklinikum Schleswig-Holstein - Campus Kiel, Kiel, Not set

Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz, Not set

Universitatsklinikum Munster, Muenster, Not set

Clinexpert Kft., Budapest, Not set

Obudai Egeszsegugyi Centrum Kft., Budapest, Not set

Geomedical Orvosi Kft., Budapest, Not set

Semmelweis Egyetem, Budapest, Not set

Debreceni Egyetem Klinikai Kozpon Belgyogy Klinika, Debrecen, Not set

Bacs-Kiskun Varmegyei Oktatokorhaz, Kecskemet, Not set

Pecsi Tudomanyegyetem, Pecs, Not set

Szegedi Tudomanyegyetem Aok Szent-Gyorgyi Albert Klinikai Kozpont, Szeged, Not set

Azienda Ospedaliero Universitaria Policlinico G.Rodolico San Marco, Catania, Not set

Fondazione Irccs Ca Granda Ospedale Maggiore, Milano, Not set

Azienda Ospedaliera Universitaria Federico Ii, Napoli, Not set

Azienda Ospedale-Università Di Padova, Padova, Not set

Fondazione Policlinico Universitario Agostino Gemelli Irccs, Roma, Not set

Umc Utrecht, Utrecht, Not set

Centrum Badan Klinicznych Pi-House Sp. Z O.O., Gdansk, Not set

Gyncentrum Sp Z O O, Katowice, Not set

Centrum Medyczne All Med Badania Kliniczne, Krakow, Not set

Diamond Clinic Specjalistyczne Poradnie Lekarskie, Krakow, Not set

Dermoklinika, Lodz, Not set

Clinical Best Solutions, Lublin, Not set

Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, Not set

Mics Centrum Medyczne Torun, Torun, Not set

Etg Warszawa, Warsaw, Not set

Mics Centrum Medyczne Warszawa, Warszawa, Not set

High-Med Przychodnia Specjalistycza, Warszawa, Not set

Centrum Medyczne Evimed, Warszawa, Not set

Dermmedica Sp. Z O.O., Wrocław, Not set

Hospital General Unviersitario de Alicante, Alicante, Not set

Hospital de La Santa Creu I Sant Pau, Barcelona, Not set

Hospital Sant Joan de Deu, Esplugues de Llobregat, Not set

Hospital Universitario Virgen de Las Nieves, Granada, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario de La Paz, Madrid, Not set

Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda, Not set

Hospital Regional Universitario de Malaga, Malaga, Not set

Hospital de Manises, Manises, Not set

Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Not set

West Glasgow Ambulatory Care Hospital, Glasgow, Not set

St John'S Institute of Dermatology, London, Not set

University of Nottingham Health Service, Nottingham, Not set

Sheffield Childrens Hospital, Sheffield, Not set

Walsall Manor Hospital, Walsall, Not set

The Adam Practice, Wirral, Not set

Conditions: Atopic Dermatitis

Learn More ›

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

NCT06461897

Recruiting

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Topical therapies applied over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study compares upadacitinib to dupilumab in pediatric participants with moderate to severe AD who are candidates for systemic therapy. Adverse events and change in the disease activity will be assessed. Upadacitinib is an approved drug... Read More

Gender:

ALL

Ages:

Between 2 years and 11 years

Trial Updated:

06/27/2025

Locations: Applied Research Center Of Arkansas /ID# 268547, Little Rock, Arkansas +126 locations

Applied Research Center Of Arkansas /ID# 268547, Little Rock, Arkansas

Integrative Skin Science and Research /ID# 265108, Sacramento, California

Clearlyderm Dermatology - West Boca /ID# 266323, Boca Raton, Florida

Pediatric Skin Research /ID# 266308, Coral Gables, Florida

Neoclinical Research - Hialeah /ID# 269694, Hialeah, Florida

Cleaver Medical Group Dermatology /ID# 265099, Dawsonville, Georgia

Aeroallergy Research Laboratory /ID# 267247, Savannah, Georgia

Treasure Valley Medical Research /ID# 266838, Boise, Idaho

Sneeze Wheeze & Itch Associates /ID# 267238, Normal, Illinois

Dawes Fretzin, LLC /ID# 265097, Indianapolis, Indiana

Equity Medical, LLC /ID# 268270, Bowling Green, Kentucky

Maryland Allergy & Asthma Center /ID# 268032, Lanham, Maryland

DermAssociates - Rockville /ID# 266457, Rockville, Maryland

Washington University School of Medicine - St. Louis /ID# 268545, Saint Louis, Missouri

Skin Specialists /ID# 266331, Omaha, Nebraska

DOCS Clinical Research - Canal Winchester /ID# 268271, Canal Winchester, Ohio

Wright State Physicians Health Center /ID# 268841, Fairborn, Ohio

Medical University of South Carolina /ID# 265113, Charleston, South Carolina

International Clinical Research - Tennessee /ID# 268548, Murfreesboro, Tennessee

Arlington Research Center, Inc /ID# 266330, Arlington, Texas

3A Research - East location /ID# 267622, El Paso, Texas

Prime Clinical Research - Mansfield - East Broad Street /ID# 268042, Mansfield, Texas

Texas Dermatology and Laser Specialists /ID# 267249, San Antonio, Texas

Progressive Clinical Research - San Antonio /ID# 267262, San Antonio, Texas

Jordan Valley Dermatology & Research Center /ID# 267092, South Jordan, Utah

West Virginia University Hospitals /ID# 265114, Morgantown, West Virginia

Wisconsin Medical Center /ID# 267236, Milwaukee, Wisconsin

Monash Health - Monash Medical Centre /ID# 267149, Clayton, Victoria

Institute for Skin, Health and Immunity /ID# 266158, Mitcham, Victoria

Medizinische Universitaet Graz /ID# 262741, Graz, Steiermark

Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 265427, Salzburg, Not set

Medizinische Universitaet Wien /ID# 265417, Wien, Not set

Irmandade da Santa Casa de Misericórdia de Porto Alegre /ID# 267455, Porto Alegre, Rio Grande Do Sul

Hospital e Maternidade Celso Pierro - PUC-Campinas /ID# 266965, Campinas, Sao Paulo

Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto /ID# 266964, Ribeirão Preto, Sao Paulo

Clinica de Alergia Martti Antila /ID# 266197, Sorocaba, Sao Paulo

Medical Center Cordis /ID# 265250, Pleven, Not set

UMHAT Alexandrovska EAD /ID# 265256, Sofiya, Not set

Dermatology Research Institute - Blackfoot Trail /ID# 266744, Calgary, Alberta

Rejuvenation Dermatology - Edmonton Downtown /ID# 267871, Edmonton, Alberta

Maritime Dermatology /ID# 267359, Halifax, Nova Scotia

Leader Research /ID# 266745, Hamilton, Ontario

Triple A Lab Inc /ID# 266615, Hamilton, Ontario

Lynde Institute for Dermatology /ID# 267006, Markham, Ontario

Allergy Research Canada /ID# 270230, Niagara Falls, Ontario

DermAtelier on Avenue /ID# 267850, Toronto, Ontario

Beijing Children's Hospital /ID# 266350, Beijing, Beijing

Xiamen Children's Hospital /ID# 266384, Xia Men, Fujian

Henan Children's Hospital Zhengzhou Children's Hospital /ID# 266832, Zhengzhou, Henan

Hunan Children's Hospital /ID# 266365, Changsha, Hunan

Dalian Medical University - Dalian Children's Hospital /ID# 266675, Dalian, Liaoning

Chengdu Women and Children Center Hospital /ID# 266402, Chengdu, Sichuan

Kunming Children's Hospital /ID# 266555, Kunming, Yunnan

Klinika za dječje bolesti Zagreb /ID# 264936, Zagreb, Grad Zagreb

Poliklinika DermaPlus /ID# 265724, Zagreb, Grad Zagreb

Poliklinika Solmed /ID# 265070, Zagreb, Grad Zagreb

Klinicki Bolnicki Centar (KBC) Split /ID# 265359, Split, Splitsko-dalmatinska Zupanija

Specialty hospital Medico /ID# 266116, Rijeka, Not set

CHU Toulouse - Hopital Larrey /ID# 255048, Toulouse, Haute-Garonne

Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois /ID# 265455, Vandœuvre-lès-Nancy, Meurthe-et-Moselle

CHU Bordeaux - Hopital Pellegrin /ID# 266818, Bordeaux, Nouvelle-Aquitaine

Centre Hospitalier Universitaire de Clermont Ferrand - Hopital Estaing /ID# 267327, Clermont-Ferrand, Puy-de-Dome

CHU Amiens-Picardie Site Sud /ID# 255083, Amiens CEDEX 1, Somme

Centre Hospitalier d'Argenteuil Victor Dupouy /ID# 265448, Argenteuil, Not set

Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu /ID# 265449, Nantes, Not set

AP-HP - Hopital Necker /ID# 255050, Paris, Not set

Universitaetsklinikum Erlangen /ID# 255168, Erlangen, Bayern

Fachklinik Bad Bentheim /ID# 255165, Bad Bentheim, Niedersachsen

Universitaetsklinikum Muenster /ID# 255166, Muenster, Nordrhein-Westfalen

Universitaetsklinikum Carl Gustav Carus Dresden /ID# 255167, Dresden, Sachsen

Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 267411, Berlin, Not set

DermaMed Research - Oroshaza /ID# 266995, Oroshaza, Bekes

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont /ID# 265653, Szeged, Csongrad

Debreceni Egyetem-Klinikai Kozpont /ID# 265331, Debrecen, Hajdu-Bihar

Soroka Medical Center /ID# 265251, Be'er Sheva, HaDarom

HaEmek Medical Center /ID# 266416, Afula, Haifa

Schneider Childrens Medical Center of Israel /ID# 265617, Petah Tikva, HaMerkaz

The Chaim Sheba Medical Center /ID# 265254, Ramat Gan, Tel-Aviv

Hadassah Medical Center-Hebrew University /ID# 255041, Jerusalem, Yerushalayim

Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 267070, Rome, Roma

IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 255118, Bologna, Not set

Korea University Ansan Hospital /ID# 264169, Ansan-si, Gyeonggido

Soon Chun Hyang University Hospital Bucheon /ID# 264171, Bucheon-si, Gyeonggido

Chungang University Hospital /ID# 266383, Dongjak-gu, Seoul Teugbyeolsi

Seoul National University Hospital /ID# 264176, Seoul, Seoul Teugbyeolsi

Konkuk University Medical Center /ID# 264178, Seoul, Seoul Teugbyeolsi

Hallym University Kangnam Sacred Heart Hospital /ID# 267318, Seoul, Seoul Teugbyeolsi

Amsterdam UMC, locatie AMC /ID# 265406, Amsterdam, Noord-Holland

Erasmus Medisch Centrum /ID# 265408, Rotterdam, Zuid-Holland

MICS Centrum Medyczne Torun / Nasz Lekarz Przychodnie Medyczne /ID# 265454, Torun, Kujawsko-pomorskie

Centrum Nowoczesnych Terapii 'Dobry Lekarz' sp.z.o.o. /ID# 266030, Krakow, Malopolskie

Royalderm Agnieszka Nawrocka /ID# 266606, Warsaw, Mazowieckie

Klinika Osipowicz & Turkowski sp.z.o.o /ID# 267490, Warszawa, Mazowieckie

Clinical Research Group Sp. z o.o. /ID# 266924, Warszawa, Mazowieckie

Klinika Ambroziak Dermatologia /ID# 265458, Warszawa, Mazowieckie

NZOZ Specjalistyczny Osrodek Dermatologiczny Dermal /ID# 266613, Bialystok, Podlaskie

Centrum Badan Klinicznych PI-House sp. z o.o. /ID# 265451, Gdansk, Pomorskie

Centrum Medyczne Angelius Provita /ID# 265456, Katowice, Slaskie

Specjalistyczny Niepubliczny Zaklad Opieki Zdrowotnej Alergologia Plus /ID# 265457, Poznan, Wielkopolskie

Unidade Local de Saude de Coimbra, EPE /ID# 266115, Coimbra, Not set

Unidade Local de Saude de Santo Antonio, E.P.E. /ID# 266112, Porto, Not set

Unidade Local de Saude de Sao Joao, EPE /ID# 266111, Porto, Not set

Clinical Research Investigator Group, LLC /ID# 268366, Bayamon, Not set

Private Practice - Dr. Alma Cruz /ID# 264234, Carolina, Not set

National University Hospital /ID# 265685, Singapore, Not set

KK Women's and Children's Hospital /ID# 266519, Singapore, Not set

Narodny Ustav Detskych Chorob /ID# 265253, Bratislava, Bratislavsky Kraj

ALERSA, s.r.o. /ID# 266245, Kosice, Kosicky Kraj

Univerzitna nemocnica L. Pasteura Kosice /ID# 265239, Košice, Kosicky Kraj

Univerzitna nemocnica Martin /ID# 265947, Martin, Zilinsky Kraj

Fakultna nemocnica Trnava /ID# 265245, Trnava, Not set

Hospital Sant Joan de Deu /ID# 255287, Esplugues de Llobregat, Barcelona

Hospital General Universitario Gregorio Maranon /ID# 255288, Madrid, Not set

Hospital Universitario La Paz /ID# 255286, Madrid, Not set

Consorci Hospital General Universitario de Valencia /ID# 255289, Valencia, Not set

Hospital Universitario Miguel Servet /ID# 255290, Zaragoza, Not set

Kaohsiung Chang Gung Memorial Hospital /ID# 267791, Kaohsiung City, Kaohsiung

National Taiwan University Hospital /ID# 265510, Taipei City, Taipei

New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical /ID# 266349, New Taipei City, Not set

Taipei Veterans General Hospital /ID# 265507, Taipei City, Not set

Linkou Chang Gung Memorial Hospital /ID# 263664, Taoyuan City, Not set

Derriford Hospital and the Royal Eye Infirmary /ID# 266980, Plymouth, Devon

Chelsea and Westminster Hospital /ID# 266389, London, Greater London

St. George's Hospital /ID# 266984, London, Greater London

Queen Elizabeth University Hospital /ID# 265219, Glasgow, Lanarkshire

Manchester University NHS Foundation Trust /ID# 267693, Manchester, Not set

Royal Victoria Infirmary /ID# 265238, Newcastle upon Tyne, Not set

Conditions: Atopic Dermatitis

Learn More ›

Natural History and Genetics of Food Allergy and Related Conditions

NCT02504853

Recruiting

Background: - About 15 million Americans have a food allergy. Because there are no cures or effective prevention or treatment for food allergies, researchers want to learn more about them. Objective: - To learn more about the causes and effects of food allergy and related conditions. Eligibility: * People ages 2 99 who have food allergy and/or a related genetic or other condition * Their relatives * Healthy relatives and volunteers Design: * Participants will have at least 3 visits over 1... Read More

Gender:

ALL

Ages:

Between 1 day and 99 years

Trial Updated:

06/27/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Food Allergy, Loeys-Dietz Syndrome, Atopic Dermatitis, Eosinophilic Esophagitis

Learn More ›

A Study Evaluating APG777 in Atopic Dermatitis

NCT06395948

Recruiting

This is a two-part study that will evaluate the safety and efficacy of APG777 in participants with moderate-to-severe Atopic Dermatitis (AD). Part A (Proof-of-concept) and Part B (Dose-regimen Finding) will evaluate the safety and efficacy of various induction and maintenance dose regimens of APG777 compared to placebo. The study duration for any individual participant will be up to 106 weeks which includes: screening, induction, maintenance, and post-treatment follow-up periods. Participants ra... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/26/2025

Locations: Investigational Site #14, Fountain Valley, California +83 locations

Investigational Site #14, Fountain Valley, California

Investigational Site # 46, Los Angeles, California

Investigational Site # 8, San Diego, California

Investigational Site # 44, New Haven, Connecticut

Investigational Site # 1, Coral Gables, Florida

Investigational site #48, Jacksonville, Florida

Investigational Site # 21, Margate, Florida

Investigational site #47, Douglasville, Georgia

Investigational Site # 36, Skokie, Illinois

Investigational Site # 38, West Lafayette, Indiana

Investigational site #50, Bowling Green, Kentucky

Investigational Site # 2, Rockville, Maryland

Investigational Site # 43, Detroit, Michigan

Investigational Site #10, Troy, Michigan

Investigational Site #16, Portsmouth, New Hampshire

Investigational site #49, New York, New York

Investigational Site # 3, Wilmington, North Carolina

Investigational Site # 31, Boardman, Ohio

Investigational Site #12, Mason, Ohio

Investigational Site #22, Portland, Oregon

Investigational Site # 34, Pittsburgh, Pennsylvania

Investigational Site # 37, Charleston, South Carolina

Investigational Site # 4, Nashville, Tennessee

Investigational Site # 23, Dallas, Texas

Investigational Site # 33, Dallas, Texas

Investigational Site # 18, San Antonio, Texas

Investigational Site # 5, Norfolk, Virginia

Investigational Site # 7, Mill Creek, Washington

Investigational Site # 26, Calgary, Alberta

Investigational Site #51, Calgary, Alberta

Investigational Site # 32, Edmonton, Alberta

Investigational site #73, Vancouver, British Columbia

Investigational Site #19, Winnipeg, Manitoba

Investigational Site #15, Fredericton, New Brunswick

Investigational site #52, Ajax, Ontario

Investigational Site # 9, Markham, Ontario

Investigational Site # 25, Mississauga, Ontario

Investigational site #53, Ottawa, Ontario

Investigational Site #13, Peterborough, Ontario

Investigational Site # 20, Toronto, Ontario

Investigational Site # 24, Toronto, Ontario

Investigational Site #11, Toronto, Ontario

Investigational Site # 6, Montreal, Quebec

Investigational Site #17, Québec, Quebec

Investigational site #54, Prague, Not set

Investigational site #81, Prague, Not set

Investigational site #59, Prague, Not set

Investigational site #57, Prague, Not set

Investigational site #80, Rouen, Normandie

Investigational site #83, Nantes, Not set

Investigational site #82, Heidelberg, Baden-Wurttemberg

Investigational site #63, Tuebingen, Baden-Württemberg

Investigational site #76, Augsburg, Bavaria

Investigational site #62, München, Bayern

Investigational site #58, Blankenfelde-Mahlow, Brandenburg

Investigational site #61, Darmstadt, Hessen

Investigational site #65, Frankfurt, Hesse

Investigational site #74, Bad Bentheim, Lower Saxony

Investigational site #79, Münster, North Rhine Westfalia

Investigational site #78, Dresden, Saxony

Investigational site #75, Kiel, Schleswig-Holstein

Investigational site #64, Luebeck, Schleswig-Holstein

Investigational site #60, Berlin, Not set

Investigational site #55, Hamburg, Not set

Investigational site #72, Debrecen, Hajdú-Bihar

Investigational Site # 35, Wrocław, Dolnoslaskie

Investigational Site # 39, Wrocław, Dolnoslaskie

Investigational Site # 40, Lublin, Lubelskie

Investigational Site # 42, Warsaw, Mazowieckie

Investigational Site # 27, Warszawa, Mazowieckie

Investigational Site # 41, Gdańsk, Pomorskie

Investigational Site # 28, Katowice, Silesia

Investigational Site # 29, Sosnowiec, Silesia

Investigational Site # 30, Kraków, Woj. Małopolskie

Investigational site #56, Szczecin, Zachodniopomorskie

Investigational Site # 45, Łódź, Łódzkie

Investigational site #66, Santiago De Compostela, A Coruña

Investigational site #71, Badalona, Barcelona

Investigational site #68, Las Palmas De Gran Canaria, Islas Canarias

Investigational site #70, Alicante, Not set

Investigational site #84, Barcelona, Not set

Investigational site #69, Madrid, Not set

Investigational site #67, Madrid, Not set

Investigational site #77, Zaragoza, Not set

Conditions: Atopic Dermatitis

Learn More ›

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

NCT05559359

Recruiting

The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18 years of age with moderate-to-severe atopic dermatitis (AD).

Gender:

ALL

Ages:

Between 6 months and 17 years

Trial Updated:

06/25/2025

Locations: Clinical Research Center of Alabama, Birmingham, Alabama +83 locations

Clinical Research Center of Alabama, Birmingham, Alabama

Phoenix Children's Hospital, Phoenix, Arizona

Arkansas Research Trials, North Little Rock, Arkansas

First OC Dermatology, Fountain Valley, California

Antelope Valley Clinical Trials, Lancaster, California

Dermatology Research Associates, Los Angeles, California

Integrative Skin Science and Research - Location 2, Sacramento, California

UConn Health, Farmington, Connecticut

Solutions Through Advanced Research, Jacksonville, Florida

ForCare Clinical Research, Tampa, Florida

Treasure Valley Medical Research, Boise, Idaho

Northwestern University, Chicago, Illinois

Allergy & Asthma Specialists, P.S.C., Owensboro, Kentucky

Respiratory Medicine Research Institute of Michigan, PLC, Ypsilanti, Michigan

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

Wright State Physicians, Fairborn, Ohio

Medical University of South Carolina, Charleston, South Carolina

Texas Dermatology and Laser Specialists, San Antonio, Texas

Medical College of Wisconsin, Milwaukee, Wisconsin

Instituto de Neumonología Y Dermatología, Ciudad Autonoma de Buenos Aires, Buenos Aires

Psoriahue, Ciudad Autonoma de Buenos Aires, Buenos Aires

Fundacion Estudios Clinicos, Rosario, Santa Fe

CONEXA Investigacion Clinica S.A., Buenos Aires, Not set

Fundación Respirar, Buenos Aires, Not set

Centro de Investigaciones Metabólicas (CINME), Ciudad Autónoma de Buenos Aires, Not set

Sydney Children's Hospital, Randwick, New South Wales

The Children's Hospital at Westmead, Westmead, New South Wales

Cornerstone Dermatology, Coorparoo, Queensland

Veracity Clinical Research, Woolloongabba, Queensland

Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul

Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, São Paulo

Centro de Pesquisa Sao Lucas, Campinas, São Paulo

Hospital de Clínicas de Ribeirão Preto, Ribeirão Preto, São Paulo

Faculdade de Medicina do ABC, Santo Andre, São Paulo

Clinica de Alergia Martti Antila, Sorocaba, São Paulo

IBPClin - Instituto Brasil de Pesquisa Clínica, Rio de Janeiro, Not set

Dermatology Research Institute, Calgary, Alberta

DermEdge Research, Mississauga, Ontario

Detska nemocnice FN Brno, Brno, Brno-město

Fakultni nemocnice Bulovka, Prague, Praha 8

Rosenpark Research GmbH, Darmstadt, Hessen

Universitätsklinikum Frankfurt, Frankfurt, Hessen

Fachklinik Bad Bentheim, Bad Bentheim, Niedersachsen

Universitätsklinikum Münster, Münster, Nordrhein-Westfalen

Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Sachsen

Fujita Health University, Toyoake, Aichi

Fukuyama City Hospital, Fukuyama, Hiroshima

Asahikawa Medical College Hospital, Asahikawa, Hokkaido

National Hospital Organization Sagamihara National Hospital, Sagamihara, Kanagawa

Ina Central Hospital, Ina, Nagano

Osaka Habikino Medical Center, Habikino, Osaka

Dermatology and Ophthalmology Kume Clinic, Sakai City, Osaka

Enomoto Clinic, Kumagaya, Saitama

Sugamo Sengoku Dermatology, Toshima, Tokyo

Hiroshima University Hospital, Hiroshima, Not set

University Hospital,Kyoto Prefectural University of Medicine, Kyoto, Not set

Okayama City General Medical Center Okayama City Hospital, Okayama, Not set

Hospital de Jesús Nazareno, Mexico City, Distrito Federal

Trials in Medicine, Mexico City, Distrito Federal

Hospital Infantil de Mexico Federico Gomez, Mexico City, Distrito Federal

Instituto Dermatologico de Jalisco, Zapopan, Jalisco

PanAmerican Clinical Research - Cuernavaca, Cuernavaca, Morelos

Eukarya PharmaSite, Monterrey, Nuevo León

Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo León

Scientia Investigacion Clinica S.C., Chihuahua, Not set

Arké SMO S.A de C.V, Veracruz, Not set

Centrum Medyczne Evimed, Warsaw, Mazowieckie

Diamond Clinic, Krakow, Małopolskie

Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk, Pomorskie

"DERMED" Centrum Medyczne Sp. z o.o., Lodz, Łódzkie

Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona [Barcelona]

Hospital Universitario de Gran Canaria Doctor Negrín, Las, Las Palmas

Clinica Universidad de Navarra, Pamplona, Navarra

Grupo Pedro Jaén, Madrid, Not set

Hospital Infantil Universitario Niño Jesús, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist, Kaohsiung

Chung Shan Medical University Hospital, Taichung City, Taichung

National Taiwan University Hospital - Hsinchu branch, Hsinchu, Not set

National Taiwan University Hospital, Taipei, Not set

Chang Gung Memorial Hospital-Taipei, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Not set

Conditions: Atopic Dermatitis, Eczema

Learn More ›

A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis

NCT06718101

Recruiting

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. The purpose of this study is to evaluate the clinical efficacy and safety of single therapies and/or combination therapies for moderate to severe AD through multiple substudies. This study will consist of multiple sub-studies, Sub-Study 1 will have a randomized, placebo controlled period 1 followed by a lutikizumab treatment period 2 enrolling 80 participants at a 1 to 1 ratio. In Sub-... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/25/2025

Locations: Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272550, Fountain Hills, Arizona +23 locations

Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272550, Fountain Hills, Arizona

Dermatology Research Associates - Los Angeles /ID# 272945, Los Angeles, California

Integrative Skin Science and Research /ID# 274243, Sacramento, California

Clinical Trials Research Institute /ID# 274234, Thousand Oaks, California

Western States Clinical Res /ID# 271748, Wheat Ridge, Colorado

Skin Care Research Boca Raton /ID# 272544, Boca Raton, Florida

Research Associates of South Florida /ID# 272549, Miami, Florida

Advanced Clinical Research Institute /ID# 272558, Tampa, Florida

Encore Medical Research - Weston /ID# 272539, Weston, Florida

Arlington Dermatology /ID# 271735, Rolling Meadows, Illinois

Somnos Clinical Research /ID# 272943, Lincoln, Nebraska

Equity Medical, LLC /ID# 272555, New York, New York

Oregon Dermatology & Research Center /ID# 271733, Portland, Oregon

Clinical Partners /ID# 271791, Johnston, Rhode Island

Health Concepts /ID# 271744, Rapid City, South Dakota

Orion Clinical Research /ID# 274236, Austin, Texas

Complete Dermatology - Sugar Land /ID# 274240, Sugar Land, Texas

Dermatology Associates of Tyler /ID# 273684, Tyler, Texas

Center for Clinical Studies - Clear Lake /ID# 271749, Webster, Texas

Medical Corporation Kojinkai Sapporo Dermatology Clinic /ID# 273619, Sapporo-shi, Hokkaido

Tachikawa Dermatology Clinic /ID# 273620, Tachikawa-shi, Tokyo

Korea University Ansan Hospital /ID# 271786, Ansan-si, Gyeonggido

Soon Chun Hyang University Hospital Bucheon /ID# 271788, Bucheon-si, Gyeonggido

Hallym University Kangnam Sacred Heart Hospital /ID# 271785, Seoul, Seoul Teugbyeolsi

Conditions: Atopic Dermatitis

Learn More ›

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

NCT06389136

Recruiting

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study aims to provide data on the efficacy and safety of upadacitinib at different doses in adult participants with moderate to severe AD. Upadacitinib is an approved drug for the treatment of moderate to severe atopic dermatitis (AD). This stud... Read More

Gender:

ALL

Ages:

Between 18 years and 63 years

Trial Updated:

06/25/2025

Locations: Clinical Trials Institute - Northwest Arkansas /ID# 267290, Fayetteville, Arkansas +95 locations

Clinical Trials Institute - Northwest Arkansas /ID# 267290, Fayetteville, Arkansas

Private Practice - Dr. Tooraj Raoof /ID# 263849, Encino, California

Allergy & Asthma Associates of Southern California - Mission Viejo /ID# 266574, Mission Viejo, California

Dermatologist Medical Group of North County- Profound Research /ID# 266512, Oceanside, California

Stanford University School of Medicine - Redwood City /ID# 263776, Redwood City, California

Integrative Skin Science and Research /ID# 264537, Sacramento, California

West Dermatology La Jolla /ID# 265014, San Diego, California

Clinical Trials Research Institute /ID# 263846, Thousand Oaks, California

Yale University School of Medicine /ID# 263836, New Haven, Connecticut

Clearlyderm Dermatology - West Boca /ID# 264923, Boca Raton, Florida

Skin Care Research Boca Raton /ID# 263733, Boca Raton, Florida

Apex Clinical Trials /ID# 263747, Brandon, Florida

TrueBlue Clinical Research /ID# 265037, Brandon, Florida

Life Clinical Trials /ID# 267195, Coral Springs, Florida

Revival Research - Doral /ID# 263541, Doral, Florida

Skin Care Research - Hollywood /ID# 263739, Hollywood, Florida

Solutions Through Advanced Research /ID# 263392, Jacksonville, Florida

GSI Clinical Research, LLC /ID# 263760, Margate, Florida

Quality Research of South Florida /ID# 266496, Miami Lakes, Florida

Research Associates of South Florida /ID# 267291, Miami, Florida

International Dermatology Research /ID# 264961, Miami, Florida

Sullivan Dermatology /ID# 263537, Miami, Florida

Lenus Research and Medical Group /ID# 263779, Miami, Florida

Global Clinical Professionals (GCP) /ID# 266474, Saint Petersburg, Florida

Skin Care Research - Tampa /ID# 263750, Tampa, Florida

Alliance Clinical Research of Tampa /ID# 264531, Tampa, Florida

Centricity Research Columbus Dermatology /ID# 266529, Columbus, Georgia

Cleaver Medical Group Dermatology /ID# 263788, Dawsonville, Georgia

Georgia Skin & Cancer Clinic /ID# 267199, Savannah, Georgia

Treasure Valley Medical Research /ID# 263738, Boise, Idaho

DeNova Research /ID# 264513, Chicago, Illinois

Northwestern University Feinberg School of Medicine /ID# 264983, Chicago, Illinois

Dawes Fretzin, LLC /ID# 264534, Indianapolis, Indiana

Options Research Group /ID# 264564, West Lafayette, Indiana

Dermatology Specialists Research (DS Research) - Kentucky /ID# 263388, Louisville, Kentucky

Velocity Clinical Research at The Dermatology Clinic - Baton Rouge /ID# 267169, Baton Rouge, Louisiana

Boston Specialists /ID# 265810, Boston, Massachusetts

Beth Israel Deaconess Medical Center /ID# 263703, Boston, Massachusetts

Beacon Clinical Research /ID# 263843, Quincy, Massachusetts

Great Lakes Research Group - Bay City /ID# 263535, Bay City, Michigan

Henry Ford Medical Center - New Center One /ID# 263522, Detroit, Michigan

Onyx Clinical Research - Flint - South Linden Road /ID# 267773, Flint, Michigan

MediSearch Clinical Trials /ID# 263579, Saint Joseph, Missouri

Physician Research Collaboration, LLC /ID# 263583, Lincoln, Nebraska

Skin Specialists /ID# 263345, Omaha, Nebraska

Skin Cancer and Dermatology Institute - Reno /ID# 263771, Reno, Nevada

Dartmouth Hitchcock Medical Center - Old Etna Road /ID# 263840, Lebanon, New Hampshire

Forest Hills Dermatology Group @ Union Turnpike /ID# 263755, Kew Gardens, New York

Equity Medical, LLC /ID# 265814, New York, New York

Weill Cornell Medicine /ID# 265793, New York, New York

Piedmont Plastic Surgery and Dermatology /ID# 266545, Huntersville, North Carolina

Vital Prospects Clinical Research Institute - Tulsa /ID# 263645, Tulsa, Oklahoma

Oregon Health and Science University /ID# 263736, Portland, Oregon

Dermatology Partners /ID# 264972, Philadelphia, Pennsylvania

University of Pittsburgh Medical Center /ID# 264526, Pittsburgh, Pennsylvania

Dermatology Associates of Plymouth Meeting /ID# 267286, Plymouth Meeting, Pennsylvania

Medical University of South Carolina /ID# 263655, Charleston, South Carolina

ADCS - Spartanburg /ID# 267185, Spartanburg, South Carolina

Arlington Research Center, Inc /ID# 263665, Arlington, Texas

Orion Clinical Research /ID# 263658, Austin, Texas

Bellaire Dermatology Associates /ID# 263794, Bellaire, Texas

Studies in Dermatology LLC /ID# 263335, Cypress, Texas

Dermatology Treatment and Research Center /ID# 265812, Dallas, Texas

Modern Research Associates /ID# 263852, Dallas, Texas

The Dermatology Institute of South Texas /ID# 267332, McAllen, Texas

Texas Dermatology Research Center /ID# 264528, Plano, Texas

Stride Clinical Research /ID# 267331, Sugar Land, Texas

The Woodlands Dermatology Associates /ID# 266547, The Woodlands, Texas

Dermatology Associates of Tyler /ID# 264980, Tyler, Texas

West Virginia Research Institute - Morgantown /ID# 264930, Morgantown, West Virginia

Dermatology Research Institute - Blackfoot Trail /ID# 270450, Calgary, Alberta

Stratica Medical /ID# 270466, Edmonton, Alberta

Centre de Recherche Saint-Louis /ID# 271083, Québec, Quebec

Centro de Inmunología y Genética CIGE SAS /ID# 266200, Medellín, Antioquia

Centro Integral de Reumatología del Caribe SAS - Circaribe SAS /ID# 265088, Barranquilla, Atlantico

Centro de Investigacion en Reumatologia y especialidades Medicas S.A.S- CIREEM /ID# 265092, Bogotá, Cundinamarca

Unidad Integral de Endocrinologia (UNIENDO) /ID# 266970, Bogotá, Cundinamarca

Ichinomiya Municipal Hospital /ID# 265068, Ichinomiya, Aichi

Takeoka Dermatology Clinic /ID# 264055, Marugame, Kagawa

Kawasaki Medical School Hospital /ID# 266164, Kurashiki, Okayama

Dokkyo Medical University Hospital /ID# 265431, Mibu, Tochigi

Tachikawa Dermatology Clinic /ID# 271912, Tachikawa-shi, Tokyo

Katahira Dermatology Urology Clinic /ID# 264403, Kagoshima, Not set

NTT Medical Center Tokyo /ID# 265104, Tokyo, Not set

Teikyo University Hospital /ID# 265126, Tokyo, Not set

Korea University Ansan Hospital /ID# 263330, Ansan-si, Gyeonggido

Soon Chun Hyang University Hospital Bucheon /ID# 263331, Bucheon-si, Gyeonggido

Ajou University Hospital /ID# 263328, Suwon-si, Gyeonggido

Seoul National University Hospital /ID# 263329, Seoul, Seoul Teugbyeolsi

Konkuk University Medical Center /ID# 263327, Seoul, Seoul Teugbyeolsi

SCB Research Center /ID# 263217, Bayamon, Not set

Private Practice - Dr. Samuel Sanchez /ID# 263199, Caguas, Not set

Private Practice - Dr. Alma Cruz /ID# 263216, Carolina, Not set

Clinical Research Puerto Rico /ID# 263197, San Juan, Not set

GCM Medical Group, PSC /ID# 263218, San Juan, Not set

Caribbean Medical Research Center /ID# 267163, San Juan, Not set

Conditions: Atopic Dermatitis

Learn More ›

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

NCT07003425

Recruiting

This is a multicenter, double-blind, Long-Term Extension (LTE) study to evaluate the long-term safety and efficacy of APG777 in patients with moderate-to-severe AD who have completed treatment in an APG777 Parent Study (NCT06395948). The LTE study will consist of 3 periods: 1) Screening Visit will coincide with the last visit of the Maintenance Period in the Parent Study 2) Extended Treatment Period 3) Post-treatment Follow-up Period. This study will be conducted in participants with atopic de... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/25/2025

Locations: Investigational Site #25, Fountain Valley, California +31 locations

Investigational Site #25, Fountain Valley, California

Investigational Site #1, Coral Gables, Florida

Investigational Site #22, Margate, Florida

Investigational Site #28, Detroit, Michigan

Investigational Site #4, Troy, Michigan

Investigational Site #29, Wilmington, North Carolina

Investigational Site #32, Boardman, Ohio

Investigational Site #27, Mason, Ohio

Investigational Site #31, Portland, Oregon

Investigational Site #23, Nashville, Tennessee

Investigational Site #30, Frisco, Texas

Investigational Site #26, San Antonio, Texas

Investigational Site #6, Calgary, Alberta

Investigational Site #10, Edmonton, Alberta

Investigational Site #7, Fredericton, Brunswick

Investigational Site #3, Markham, Ontario

Investigational Site #5, Mississauga, Ontario

Investigational Site #24, Peterborough, Ontario

Investigational Site #11, Toronto, Ontario

Investigational Site #12, Toronto, Ontario

Investigational Site #9, Toronto, Ontario

Investigational Site #2, Montréal, Quebec

Investigational Site #8, Quebec City, Quebec

Investigational Site #14, Wrocław, Dolnoslaskie

Investigational Site #19, Wrocław, Dolnośląskie

Investigational Site #15, Lublin, Lubelskie

Investigational Site #18, Warszawa, Mazowieckie

Investigational Site #17, Gdańsk, Pomorskie

Investigational Site #13, Katowice, Silesia

Investigational Site #16, Sosnowiec, Silesia

Investigational Site #20, Kraków, Woj. Małopolskie

Investigational Site #21, Łódź, Not set

Conditions: Atopic Dermatitis

Learn More ›

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

NCT07011706

Recruiting

This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.

Gender:

ALL

Ages:

Between 18 years and 70 years

Trial Updated:

06/24/2025

Locations: Aclaris Study Site, Bryant, Arkansas +20 locations

Conditions: Atopic Dermatitis, Atopic, Dermatitis, AD, Eczema

Learn More ›

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

NCT05995964

Recruiting

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic dermatitis (AD). AD is a long- lasting itchy red rash, caused by a skin reaction. This study is seeking participants who: * are 18 years of age or more. * Were confirmed to have AD at least 6 months ago. * Are not having an effective treatment result from medicines that are applied on skin for AD. * Are considered by their doctors to have moderate to severe AD. In Stage 1 of the study, participants will receive either PF-07275315 or PF-07264660 or placebo. Stage 1 is complete. In Stage 2 of the study participants will receive either PF-07275315 or placebo. In Stage 3 of the study participants who have received anti-inflammatory proteins, will receive either PF-07275315 or placebo. A placebo does not have any medicine in it but looks just like the medicines being studied. PF-07275315 or PF-07264660 or placebo will be given as multiple shots in the clinic over the course of 12 weeks. Stage 1 participants will receive shots at the study clinic on Day 1, Week 1, Week 2, Week 4, Week 6, Week 8, Week 10 and Week 12. Stage 2 participants will receive shots at the study clinic on Day 1, Week 4, Week 8 and Week 12. Stage 3 participants will receive shots at the study clinic on Day 1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24 and Week 28. The experiences of people receiving PF-07275315 or PF-07264660 will be compared to people who do not. This will help determine if PF-07275315 and PF-07264660 are safe and effective. Participants in Stage 1 and 2 will be involved in this study for up to 40 weeks (10 months). During this time, Stage 1 participants will have 13 visits at the study clinic, and Stage 2 participants will have 9 visits at the study clinic. Participants in Stage 3 will be involved in this study for up to 52 weeks (13 months); and will have 13 visits at the study clinic. Read Less

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/23/2025

Locations: Allervie Clinical Research, Birmingham, Alabama +95 locations

Allervie Clinical Research, Birmingham, Alabama

Onyx Clinical Research - Peoria, Peoria, Arizona

Medical Dermatology Specialists, Phoenix, Arizona

Onyx Clinical Research, Phoenix, Arizona

Banner - University Medicine Dermatology Clinic, Tucson, Arizona

Marvel Clinical Research, Huntington Beach, California

California Allergy and Asthma Medical Group, Los Angeles, California

University Dermatology Trials, INC., Newport Beach, California

Northridge Clinical Trials, Northridge, California

Profound Research LLC, Oceanside, California

Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc., San Diego, California

Sunwise Clinical Research, Walnut Creek, California

AboutSkin Research, LLC, Greenwood Village, Colorado

Renaissance Research and Medical Group, Cape Coral, Florida

Florida International Medical Research, Coral Gables, Florida

Revival Research, Doral, Florida

St. Jude Clinical Research, Doral, Florida

Solutions Through Advanced Research, Jacksonville, Florida

Global Health Research Center, Inc., Miami Lakes, Florida

SouthCoast Research Center, Miami, Florida

Floridian Research Institute Llc, Miami, Florida

Ziaderm Research LLC, North Miami Beach, Florida

Clinical Neuroscience Solutions, Inc., Orlando, Florida

GCP Research, Global Clinical professionals, Saint Petersburg, Florida

ForCare Clinical Research, Tampa, Florida

Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana

Southern Indiana Clinical Trials, New Albany, Indiana

Maryland Laser Skin and Vein, Hunt Valley, Maryland

Michigan Center for Research Company, Clarkston, Michigan

MI Skin Innovations, Northville, Michigan

Revival Research Institute LLC, Troy, Michigan

Revival Research Institute, LLC, Troy, Michigan

Skin Specialists, PC, Omaha, Nebraska

Empire Dermatology, East Syracuse, New York

Private Practice - Dr. Bobby Buka, New York, New York

Icahn School of Medicine at Mount Sinai, New York, New York

Sadick Research Group, New York, New York

Apex Clinical Research Center, Mayfield Heights, Ohio

Epic Medical Research - Oklahoma, Chickasha, Oklahoma

Unity Clinical Research, Oklahoma City, Oklahoma

Vital Prospects Clinical Research Institute, PC, Tulsa, Oklahoma

Velocity Clinical Research, Medford, Medford, Oregon

Paddington Testing Co, Inc, Philadelphia, Pennsylvania

Clinical Partners, LLC, Johnston, Rhode Island

National Allergy and Asthma, North Charleston, South Carolina

Spartanburg Medical Research, Spartanburg, South Carolina

Clinical Neuroscience Solutions Inc., Memphis, Tennessee

Dermatology Treatment and Research Center, Dallas, Texas

North Texas Center for Clinical Research, Frisco, Texas

Alpesh D. Desai, DO PLLC, Houston, Texas

DCT-Stone Oak, LLC dba Discovery Clinical Trials, San Antonio, Texas

Complete Dermatology, Sugar Land, Texas

Virginia Dermatology and Skin Cancer Center, Norfolk, Virginia

Momentum Darlinghurst, Darlinghurst, New South Wales

Australian Clinical Research Network, Sydney, New South Wales

Box Hill Hospital, Box Hill, Victoria

Dr Rodney Sinclair Pty Ltd, East Melbourne, Victoria

Fremantle Dermatology, Fremantle, Western Australia

Wiseman Dermatology Research Inc., Winnipeg, Manitoba

Lima's Excellence in Allergy and Dermatology Research, Hamilton, Ontario

DermEdge Research, Mississauga, Ontario

Medicor Research Inc, Sudbury, Ontario

Sudbury Skin Clinique, Sudbury, Ontario

Toronto Research Centre, Toronto, Ontario

INTERMED Groupe Sante, Chicoutimi, Quebec

Centre de Recherche Saint-Louis, Quebec, Not set

Beijing Friendship Hospital Affiliate of Capital University, Beijing, Beijing

The First Affiliated Hospital Of Fujian Medical University, Fuzhou, Fujian

Guangdong Province Dermatology Hospital, Guangzhou, Guangdong

The First Hospital of Hebei Medical University, Shijiazhuang, Hebei

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei

The Second Xiangya Hospital of Central South University, Changsha, Hunan

Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi

The first hospital of jilin university, Changchun City, Jilin

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi

Huashan Hospital, Fudan University, Shanghai, Shanghai

First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan

Hangzhou Third Hospital, Hangzhou, Zhejiang

Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang

Chengdu second people's hospital, Chengdu, Not set

Shanghai First People's Hospital, Shanghai, Not set

Fachklinik Bad Bentheim, Bad Bentheim, Niedersachsen

Magdeburger Company for Medical Studies and Services, Magdeburg, Sachsen-anhalt

Nomura Dermatology Clinic, Yokohama-city, Kanagawa

Osaka Metropolitan University Hospital, Osaka-City, Osaka

Medical Corporation Heishinkai OPHAC Hospital, Osaka-shi, Osaka

Nihonbashi Sakura Clinic, Chuo-ku, Tokyo

Fukuwa Clinic, Chuo-ku, Tokyo

Naoko Dermatology Clinic, Setagaya-ku, Tokyo

Synexus Polska Sp. z o.o. Oddzial we Wroclawiu, Wroclaw, Dolnośląskie

Pratia MCM Krakow, Kraków, Małopolskie

Niepubliczny Zakład Opieki Zdrowotnej Zespół Poradni Specjalistycznych "Termedica", Poznan, Wielkopolskie

Synexus Polska Sp. z o.o. Oddzial w Katowicach, Katowice, Not set

Centrum Medyczne Angelius Provita, Katowice, Śląskie

Dermedic Jacek Zdybski, Ostrowiec Swietokrzyski, Świętokrzyskie

Conditions: Atopic Dermatitis

Learn More ›

Topical ENS-002 for Atopic Dermatitis in Adults

NCT06469385

Recruiting

The goal of this study is to determine the safety and effects of ENS-002, a live biotherapeutic product (LBP) consisting of commensal, clonal, non-pathogenic bacteria in participants with atopic dermatitis.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/23/2025

Locations: Encore Medical Research, Hollywood, Florida +2 locations

Conditions: Atopic Dermatitis, Atopic Dermatitis Eczema

Learn More ›

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

NCT06504160

Recruiting

This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded, multi-center trial. It is designed to assess the safety and efficacy of S. hominis A9 (ShA9) topical application as a treatment for atopic dermatitis (AD). The trial will enroll adults and adolescents with atopic dermatitis who are culture positive for S. aureus colonization. The primary safety objective of this study is to compare the safety profile of ShA9 to placebo (vehicle) over 14 weeks of application, which inclu... Read More

Gender:

ALL

Ages:

12 years and above

Trial Updated:

06/23/2025

Locations: University of California, San Diego: Dermatology Clinical Trials Unit, San Diego, California +7 locations

Conditions: Atopic Dermatitis

Learn More ›

1 - 12 of 55

Browse by State

Atopic Dermatitis clinical trials in Alabama

Atopic Dermatitis clinical trials in Alaska

Atopic Dermatitis clinical trials in Arizona

Atopic Dermatitis clinical trials in Arkansas

Atopic Dermatitis clinical trials in California

Atopic Dermatitis clinical trials in Colorado

Atopic Dermatitis clinical trials in Connecticut

Atopic Dermatitis clinical trials in Delaware

Atopic Dermatitis clinical trials in District of Columbia

Atopic Dermatitis clinical trials in Florida

Atopic Dermatitis clinical trials in Georgia

Atopic Dermatitis clinical trials in Hawaii

Atopic Dermatitis clinical trials in Idaho

Atopic Dermatitis clinical trials in Illinois

Atopic Dermatitis clinical trials in Indiana

Atopic Dermatitis clinical trials in Iowa

Atopic Dermatitis clinical trials in Kansas

Atopic Dermatitis clinical trials in Kentucky

Atopic Dermatitis clinical trials in Louisiana

Atopic Dermatitis clinical trials in Maine

Atopic Dermatitis clinical trials in Montana

Atopic Dermatitis clinical trials in Nebraska

Atopic Dermatitis clinical trials in Nevada

Atopic Dermatitis clinical trials in New Hampshire

Atopic Dermatitis clinical trials in New Jersey

Atopic Dermatitis clinical trials in New Mexico

Atopic Dermatitis clinical trials in New York

Atopic Dermatitis clinical trials in North Carolina

Atopic Dermatitis clinical trials in North Dakota

Atopic Dermatitis clinical trials in Ohio

Atopic Dermatitis clinical trials in Oklahoma

Atopic Dermatitis clinical trials in Oregon

Atopic Dermatitis clinical trials in Maryland

Atopic Dermatitis clinical trials in Massachusetts

Atopic Dermatitis clinical trials in Michigan

Atopic Dermatitis clinical trials in Minnesota

Atopic Dermatitis clinical trials in Mississippi

Atopic Dermatitis clinical trials in Missouri

Atopic Dermatitis clinical trials in Pennsylvania

Atopic Dermatitis clinical trials in Rhode Island

Atopic Dermatitis clinical trials in South Carolina

Atopic Dermatitis clinical trials in South Dakota

Atopic Dermatitis clinical trials in Tennessee

Atopic Dermatitis clinical trials in Texas

Atopic Dermatitis clinical trials in Utah

Atopic Dermatitis clinical trials in Vermont

Atopic Dermatitis clinical trials in Virginia

Atopic Dermatitis clinical trials in Washington

Atopic Dermatitis clinical trials in West Virginia

Atopic Dermatitis clinical trials in Wisconsin

Atopic Dermatitis clinical trials in Wyoming